Estimated Cost of Circulating Tumor DNA for Posttreatment Surveillance of Human Papillomavirus-Associated Oropharyngeal Cancer.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 35076706.
- Also identified by DOI 10.1001/jamanetworkopen.2021.44783 and PMC identifier 8790672.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
This cross-sectional study compares the cost and effectiveness of 3 posttreatment strategies for surveillance of human papillomavirus (HPV)–associated oropharyngeal cancer.
Medical subject headings
- Carcinoma, Squamous Cell
- Circulating Tumor DNA
- Continuity of Patient Care
- Hematologic Tests
- Oropharyngeal Neoplasms